The Rise of AI-Native Therapeutic Platforms

An AI native therapeutic platform is not the same as a therapeutic platform that uses AI. The first one is designed, from the data layer up, around the kind of structured longitudinal stream that AI tools can actually do something useful with. The second one bolts a model onto an existing system and hopes for the best. The first compounds. The second mostly does not.

What AI native means in practice

AI native means the data is structured by default, the patient stream is continuous rather than episodic, the clinician's workspace consumes AI output without depending on it, and the protocol library is versioned in a way that learning can flow back into care. None of those properties are exotic. All of them require deliberate design, and they are easier to put in place at the start than to retrofit later.

Where this matters in bioelectric

In bioelectric, AI native design matters because the underlying therapy produces exactly the kind of data the AI layer benefits from. Use time, intensity, body region, patient reported outcome, and clinical notes when relevant. The Electrome platform was designed around that data shape from the start, which is why the AI layer the platform supports is useful rather than ornamental.

What it does for the patient

For the patient, AI native design shows up as a smoother experience. Fewer manual logs. Better summaries. A platform that anticipates the moments when the patient might need a touch from a clinician and surfaces them. The AI is invisible. The benefit is the experience.